Stakeholders' experiences and perceptions of male breast cancer:A qualitative evidence synthesis.

Authors:
Ye M; Qiu L; Jin Y; Huang Y.

Journal:
Breast

Publication Year: 2024

DOI:
10.1016/j.breast.2024.103694

PMCID:
PMC10904996

PMID:
38417232

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Breast

Abbreviation: Breast

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Endocrinology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
21-gene recurrence score in predicting the outcome of postoperative radiotherapy in T1-2N1 luminal …
Xie SJ; Wang RJ; Wu SG and 1 more (2024) - Transparency Score: 3/6
Axillary lymph node dissection in triple-negative or HER2-positive breast cancer patients with clin…
Guo X; Zhang J; Gong X and 24 more (2024) - Transparency Score: 3/6
Best of the year: Advanced breast cancer in 2023.
Schlam I; Chavez-MacGregor M. (2024) - Transparency Score: 3/6
"Heterogeneity of treatment effect on patients' long-term outcome according to pathological respons…
Pala L; Sala I; Pagan E and 11 more (2024) - Transparency Score: 3/6
Interactive multidisciplinary pilot workshop to improve medical student perception of and interest …
Raheel A; Dalla S; Birney J and 8 more (2024) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflict of interest statement The authors declare that they have no competing interests."

Evidence found in paper:

"Funding The present study was partially funded by the Discipline Construction Program of Shanghai Pudong New Area Health Committee (internal funding code: PWZxk2022-06)，Shanghai Hospital Association Hospital Management Research Fund (internal funding code: X2022058) and Youth Science and Technology Program of Shanghai Pudong New Area Health Committee (internal funding code: PW2021B-04). Open access funding provided by the 10.13039/501100010876Shanghai University of Traditional Chinese Medicine."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025